Brief: Tauriga Sciences, Aegea Biotechnologies To Develop Rapid, Multiplexed Novel Coronavirus Test
April 7 (Reuters) - Tauriga Sciences Inc TAUG.PK :
* TAURIGA SCIENCES INC., AEGEA BIOTECHNOLOGIES INC. ENTER
INTO
COLLABORATION AGREEMENT TO DEVELOP A RAPID, MULTIPLEXED NOVEL
CORONAVIRUS TEST
Source text for Eikon: ID:nGNX9r9wPd
Further company coverage: TAUG.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tauriga Sciences
See all newsBrief: Tauriga Sciences Says Brand Registry Application For Tauri-Gum Approved By Amazon
Brief: Tauriga Sciences Inc. To Launch Non-Fungible Tokens Creation & Content Division
Brief: Tauriga Sciences Inc Files International Patent Application
Brief: Tauriga Sciences Configures To Accept Bitcoin, Etherium, Bitcoin Cash, Dai And Litecoin Cryptocurrencies As Payment Options On E-Commerce Platform
Brief: Tauriga Sciences Confirms Product Line, Tauri-Gum Is Fully Compliant With Updated New York State Rules & Regulations